Asset Dedication LLC’s VanEck Biotech ETF BBH Stock Holding History

Asset Dedication LLC’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-83	Closed	-$16K	–	987
2021 Q4	$16K	Hold	83	–	–	﹤0.01%	577
2021 Q3	$17K	Buy	83 +23	+38%	+$4.83K	﹤0.01%	590
2021 Q2	$12K	Hold	60	–	–	﹤0.01%	589
2021 Q1	$11K	Hold	60	–	–	﹤0.01%	494
2020 Q4	$10K	Hold	60	–	–	﹤0.01%	552
2020 Q3	$10K	Hold	60	–	–	﹤0.01%	520
2020 Q2	$10K	Buy	+60	New	+$9.12K	﹤0.01%	450

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

Asset Dedication LLC's BBH Position: Q1 2022 in Review

Asset Dedication LLC sold out of VanEck Biotech ETF (BBH) in Q1 2022, closing a stake of 83 shares — an estimated $16K sold.

Asset Dedication LLC first reported a position in BBH in Q2 2020 and held it in 7 quarters. The position peaked at $17K in Q3 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.

Asset Dedication LLC reported no remaining VanEck Biotech ETF position as of Q1 2022 after selling out during the quarter.
Asset Dedication LLC sold 83 VanEck Biotech ETF shares in Q1 2022, an estimated $16K.
Asset Dedication LLC first reported a position in VanEck Biotech ETF in Q2 2020 and held it in 7 quarters.
Asset Dedication LLC's VanEck Biotech ETF position peaked at $17K in Q3 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.

Based on Asset Dedication LLC's 13F filing for Q1 2022, filed 21 Apr 2022.